Genomic Health Inc. (GHDX)
Symbol Info
Listed Symbol GHDX
Name Genomic Health Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $387,315,000
Latest Fiscal EPS $0.67
Price Info
21 Day Moving Average $69.4462
21 Day EMA $69.399860
50 Day Moving Average $72.0076
50 Day EMA $69.380310
200 Day EMA $65.782450
200 Day Moving Average 67.290150
52 Week High $92.18
52 Week Low $50.77
52 Week Change $9.458600
Alpha 0.010766
Beta 0.9031
Standard Deviation 0.118024
R2 0.069116
Periods 60
Share Information
10 Day Average Volume 320,571
20 Day Average Volume 385,000
30 Day Average Volume 381,722
50 Day Average Volume 428,552
Outstanding Shares 37,288,936
Float Shares 35,229,044
Percent Float 94.48%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 512
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 3,737,010
Institute Holdings Percent -
Institute Sold Previous 3 Months 5,190,794
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 36
Insider Holdings Percent 5.50%
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,059,892
Price Change
7 Day Price Change $-0.2799988
7 Day Percent Change -0.41%
21 Day Price Change $-2.2300034
21 Day Percent Change -3.14%
30 Day Price Change $-4.2400055
30 Day Percent Change -5.81%
Month To Date Price Change $0.9200
Month To Date Percent 1.36%
90 Day Price Change $12.539997
90 Day Percent Change 22.31%
Quarter To Date $0.919998
Quarter To Date Percent 1.36%
180 Day Price Change $2.139999
180 Day Percent Change 3.21%
200 Day Price Change $-1.940002
200 Day Percent Change -2.74%
Year To Date $4.329994
Year To Date Percent 6.72%
Profile
Description Genomic Health Inc is a healthcare company. It provides genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer. Genomic offers the tissue-based invasive breast, DCIS, prostate, and colon Oncotype DX tests as clinical laboratory services. The company operates in one business segment, which primarily focuses on the development and global commercialization of genomic-based clinical laboratory services. Genomic derives most of its revenue from the United States.
Details
Issue Type CS
Market Cap $2,563,241,461
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 37,288,936
CEO Kimberly J. Popovits
Employees 829
Last Audit UE
Classification
CIK 0001131324
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS Medical Laboratories(621511)
Info
Address 301 Penobscot Drive
Redwood City, CA 94063
Website http://www.genomichealth.com
Facisimile
Telephone +1 650 556-9300
Email investors@genomichealth.com
Key Ratios
Profitability
EBIT Margin 11.20
EBITDA Margin 14.3
Pre-Tax Profit Margin -3.7
Profit Margin Cont 11.91
Gross Margin 84.60
Profit Margin TOT 11.91
Income Statements
Revenue $318,248,000
Revenue Per Share $8.5347
Revenue 3 Years $2.74
Revenue 5 Years $5.79
Valuation Measures
PE Ratio 50.90
Enterprise Value $2,342,250,639
Price To Sales 8.054226
Price To Free Cash 54.200000
PE High Last 5 Years -
Price To Book 7.8
Price To Cash Flow 29.0
PE Low Last 5 Years -
Price To Tangible Book 7.8
Financial Strength
Total Debt To Equity 0.2
Int Coverage -
Current Ratio 5.7
Leverage Ratio 1.4
Quick Ratio 5.5
Long Term Debt To Capital 0.14
Assets
Receivables Turnover 2.7
Invoice Turnover -
Assets Turnover 0.40
Management Effectiveness
Return Assets 14.42
Return On Equity 18.48
Return On Capital 14.08
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
GHDX
Genomic He..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.